CJS Securities analyst Jonathan Tanwanteng downgrades Unisys (NYSE:UIS) from Market Outperform to Market Perform.
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
Clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) has completed its Phase 1 study evaluating proprietary oral transmucosal film (OTF) DMT formulation VLS-01 in 74 healthy participants.